BioRem Inc.
BRM.VTSXVIndustrials● Active
$3.08
+$0.04(+1.32%)
Market Cap$49948357
P/E Ratio—
52W High$3.57
52W Low$1.84
BioRem Inc. (BRM.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BRM.V · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.01
Est. $0.06 · -80.3%
Revenue
$0.01B
Est. $0.01B · -11.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
BRM.V reports quarterly as a TSXV-listed Industrial - Pollution & Treatment Controls company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 25, 2026 | $0.06 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 14, 2026 | $0.06 | $0.01 | -80.3% | $0.01B | $0.01B | -11.5% |
| ▲ Q2 FY2026 | Apr 20, 2026 | $0.10 | $0.16 | +60.6% | $0.02B | $0.01B | +25.5% |
| ▲ Q4 FY2025 | Nov 17, 2025 | $0.04 | $0.06 | +54.2% | $0.01B | $0.01B | -16.6% |
| ▼ Q3 FY2025 | Aug 25, 2025 | $0.04 | $0.04 | -9.0% | $0.01B | $0.01B | -2.8% |
| ▼ Q2 FY2025 | May 28, 2025 | $0.03 | $0.00 | -93.0% | $0.00B | $0.01B | -45.0% |
| ▼ Q2 FY2025 | Apr 16, 2025 | $0.03 | $0.01 | -66.4% | $0.01B | $0.01B | +5.8% |
| — Q4 FY2024 | Nov 6, 2024 | — | $0.12 | — | $0.01B | — | — |
Q3 FY2026
Aug 25, 2026
EPS Actual
—
EPS Est.
$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
$0.01
EPS Est.
$0.06
EPS Surpr.
-80.3%
Revenue
$0.01B
Q2 FY2026
Apr 20, 2026Beat
EPS Actual
$0.16
EPS Est.
$0.10
EPS Surpr.
+60.6%
Revenue
$0.02B
Q4 FY2025
Nov 17, 2025Beat
EPS Actual
$0.06
EPS Est.
$0.04
EPS Surpr.
+54.2%
Revenue
$0.01B
Q3 FY2025
Aug 25, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.04
EPS Surpr.
-9.0%
Revenue
$0.01B
Q2 FY2025
May 28, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.03
EPS Surpr.
-93.0%
Revenue
$0.00B
Q2 FY2025
Apr 16, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.03
EPS Surpr.
-66.4%
Revenue
$0.01B
Q4 FY2024
Nov 6, 2024
EPS Actual
$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.09 | $0.09 | $0.09 | 1 |
| Q3 FY2026 | $0.08 | $0.08 | $0.08 | 1 |
| Q2 FY2026 | $0.06 | $0.06 | $0.06 | 1 |
| Q1 FY2026 | $0.06 | $0.06 | $0.06 | 1 |
| Q4 FY2025 | $0.10 | $0.10 | $0.10 | 1 |
| Q3 FY2025 | $0.04 | $0.04 | $0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -80.3% | $3.50 | $3.51 | +0.29% |
| ▲ Q2 FY2026 | Apr 20, 2026 | +60.6% | $2.57 | $2.97 | +15.56% |
| ▲ Q4 FY2025 | Nov 17, 2025 | +54.2% | $2.15 | $2.23 | +3.72% |
| ▼ Q3 FY2025 | Aug 25, 2025 | -9.0% | $2.08 | $2.33 | +12.02% |
| ▼ Q2 FY2025 | May 28, 2025 | -93.0% | $2.00 | $1.88 | -6.00% |
| ▼ Q2 FY2025 | Apr 16, 2025 | -66.4% | $2.10 | $1.86 | -11.43% |
| — Q4 FY2024 | Nov 6, 2024 | — | $2.46 | $2.79 | +13.41% |
| — Q3 FY2024 | Aug 26, 2024 | — | $2.20 | $2.21 | +0.45% |
Q2 FY2026+0.29%
Report Date
May 14, 2026
EPS Beat/Miss
-80.3%
Price Before
$3.50
Price After
$3.51
Q2 FY2026+15.56%
Report Date
Apr 20, 2026
EPS Beat/Miss
+60.6%
Price Before
$2.57
Price After
$2.97
Q4 FY2025+3.72%
Report Date
Nov 17, 2025
EPS Beat/Miss
+54.2%
Price Before
$2.15
Price After
$2.23
Q3 FY2025+12.02%
Report Date
Aug 25, 2025
EPS Beat/Miss
-9.0%
Price Before
$2.08
Price After
$2.33
Q2 FY2025-6.00%
Report Date
May 28, 2025
EPS Beat/Miss
-93.0%
Price Before
$2.00
Price After
$1.88
Q2 FY2025-11.43%
Report Date
Apr 16, 2025
EPS Beat/Miss
-66.4%
Price Before
$2.10
Price After
$1.86
Q4 FY2024+13.41%
Report Date
Nov 6, 2024
EPS Beat/Miss
—
Price Before
$2.46
Price After
$2.79
Q3 FY2024+0.45%
Report Date
Aug 26, 2024
EPS Beat/Miss
—
Price Before
$2.20
Price After
$2.21
Avg Beat Reaction+9.64%
Avg Miss Reaction-1.28%
Beat Rate2 / 8 quarters
Largest Move+15.56% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BRM.V ends December
BioRem Inc. (BRM.V) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.01 — missing the analyst consensus of $0.06 by -80.3%. The next BRM.V earnings date is expected around September 1, 2026.
Each quarter, investors track BRM.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BRM.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BRM.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BRM.V earnings · 5 questionsBioRem Inc.'s next earnings report is expected around September 1, 2026. BRM.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BRM.V historically reports after market close (AMC).
BRM.V earnings datewhen is BRM.V earningsBRM.V next earnings datewhen does BRM.V report earningsBRM.V earnings calendar
▸ Source: FMP · BioRem Inc. SEC filings · US GAAP · BioRem Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026